377 related articles for article (PubMed ID: 18387855)
21. PPARγ activation blocks development and reduces established neuropathic pain in rats.
Morgenweck J; Griggs RB; Donahue RR; Zadina JE; Taylor BK
Neuropharmacology; 2013 Jul; 70():236-46. PubMed ID: 23415633
[TBL] [Abstract][Full Text] [Related]
22. PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway.
Zhou YQ; Liu DQ; Chen SP; Chen N; Sun J; Wang XM; Li DY; Tian YK; Ye DW
Biomed Pharmacother; 2020 Sep; 129():110356. PubMed ID: 32535388
[TBL] [Abstract][Full Text] [Related]
23. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia.
Park EJ; Park SY; Joe EH; Jou I
J Biol Chem; 2003 Apr; 278(17):14747-52. PubMed ID: 12584205
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms.
Griggs RB; Donahue RR; Morgenweck J; Grace PM; Sutton A; Watkins LR; Taylor BK
Pain; 2015 Mar; 156(3):469-482. PubMed ID: 25599238
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X
PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
[TBL] [Abstract][Full Text] [Related]
27. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
28. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
30. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
[TBL] [Abstract][Full Text] [Related]
31. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
32. Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.
Lv X; Song JG; Li HH; Ao JP; Zhang P; Li YS; Song SL; Wang XR
World J Gastroenterol; 2011 Dec; 17(48):5267-73. PubMed ID: 22219595
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
Yin Y; Hou G; Li ER; Wang QY; Kang J
Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
[TBL] [Abstract][Full Text] [Related]
34. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
[TBL] [Abstract][Full Text] [Related]
35. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
36. Possible involvement of 15-deoxy-Δ(12,14) -prostaglandin J2 in the development of leptin resistance.
Hosoi T; Matsuzaki S; Miyahara T; Shimizu K; Hasegawa Y; Ozawa K
J Neurochem; 2015 May; 133(3):343-51. PubMed ID: 25662180
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production.
Hwang J; Kleinhenz DJ; Lassègue B; Griendling KK; Dikalov S; Hart CM
Am J Physiol Cell Physiol; 2005 Apr; 288(4):C899-905. PubMed ID: 15590897
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.
Pereira MP; Hurtado O; Cárdenas A; Boscá L; Castillo J; Dávalos A; Vivancos J; Serena J; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2006 Feb; 26(2):218-29. PubMed ID: 16034372
[TBL] [Abstract][Full Text] [Related]
39. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2003 Mar; 302(2):415-20. PubMed ID: 12604364
[TBL] [Abstract][Full Text] [Related]
40. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.
Toaldo C; Pizzimenti S; Cerbone A; Pettazzoni P; Menegatti E; Daniela B; Minelli R; Giglioni B; Dianzani MU; Ferretti C; Barrera G
J Cell Mol Med; 2010 Jun; 14(6A):1347-57. PubMed ID: 19912441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
